Roorkee

About Authors:
Rahul kumar Singh
M.Pharm (Quality Assurance)
Sr. Officer Quality Assurance at Shreya Life Sciences Pvt. Ltd.,
Roorkee, Uttarakhand
rahulsingh.qa@gmail.com

Abstract
Miglitol, an oral alpha-glucosidase inhibitor, is a desoxynojirimycin derivative that delays the digestion of ingested carbohydrates, thereby resulting in a smaller rise in blood glucose concentration following meals. As a consequence of plasma glucose reduction, miglitol reduce levels of glycosylated hemoglobin in patients with Type II (non-insulin-dependent) diabetes mellitus. Systemic nonenzymatic protein glycosylation, as reflected by levels of glycosylated hemoglobin, is a function of average blood glucose concentration over time. Because its mechanism of action is different, the effect of miglitol to enhance glycemic control is additive to that of sulfonylureas when used in combination. In addition, miglitol diminishes the insulinotropic and weight-increasing effects of sulfonylureas. Miglitol has minor inhibitory activity against lactase and consequently, at the recommended doses, would not be expected to induce lactose intolerance.

Indian Institute of Technology Roorkee, Roorkee invites the applications on the prescribed form for the following posts as per details given against each.

Multani Research Foundation was established with an objective to develop & deliver best Quality Drugs affordable by needed ones based on scientific rationale and knowledge of Ayurveda. To meet its expansion plan in the area of new range of FMCG and Herbal Drugs development required following personnel.

Indian Institute of Technology Roorkee, Roorkee invites the applications on the prescribed form for the following posts as per details given against each. The application form and general conditions may be obtained from Superintendent, Establishment ‘B’ Section, IIT Roorkee.

NEEDS PHARMA, We would like to introduce ourselves a WHO - GMP certified manufacturing unit from INDIA willing to turn the milestone in Pharmaceutical era.
We manufacture Tablets, Capsule, Syrups, Suspensions and other formulations and are exporting to various countries across the Globe.

AXA Parenterals Ltd. is into manufacturing & marketing sterile of parenteral preparations, life saving medicines and hospital products.
AXA Parenterals Ltd. has first of its kind I.V. Fluid plant in Roorkee, Uttarakhand, the hilly state of India. AXA manufactures Intravenous Fluids in Polyethylene containers under aseptic conditions using the latest “State-Of-The-Art” AFFS Technology.

Indian Institute of Technology – Roorkee is among the foremost of institutes of national importance in higher technological education and in engineering, basic and applied research.